Nicola Normanno

47PUBLICATIONS
140CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Jun 25, 2026
MiR-23c Regulates the Resistance to Gefitinib in EGFR Mutant Non-Small-Cell Lung Cancer Cells.

|Apr 01, 2026
Mining cancer genomes for copy number alterations identifies glycosylation enzymes as oncogenic drivers.

Pranoy Sahu, Francesco Russo, Domenico Russo

|Mar 25, 2026
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial.

Angela Damato, Riziero Esposito Abate, Simona Tessitore

|Sep 10, 2025
Germline Findings From Tumor-Only Comprehensive Genomic Profiling in the RATIONAL Study: A Missed Opportunity?

Riziero Esposito Abate, Alessandro Morabito, Michele Milella

|Jan 27, 2025
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers.

Matthew Dankner, Emmanuelle Rousselle, Sarah Petrecca

|Jan 20, 2025
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?

Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio

Pageof 8

Frequent Collaborators

14 joint publications

Alessandro Morabito

6 joint publications

Carmine Pinto

5 joint publications

Riziero Esposito Abate

4 joint publications

Monica Rosaria Maiello